Active Pharmaceutical Ingredient (API)
Empagliflozin
SGLT2 Inhibitor (Antidiabetic/Cardioprotective)
Another highly effective SGLT2 inhibitor used for Type 2 Diabetes and reducing the risk of cardiovascular death and hospitalization for heart failure. Its mechanism involves reducing glucose reabsorption in the kidney. Empagliflozin has demonstrated compelling evidence for its cardiorenal protective effects.
Technical Profile
- Reference Code
- EMP122
- CAS Number
- 864070-44-0
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Empagliflozin as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| Jardiance 10mg OTC | Boehringer Ingelheim | Tablet (10 gm) | ₹540.00 | View Details |
| Empagliflozin 10 (Jan Aushadhi) OTC | Bureau of Pharma PSUs of India | Tablet (10 gm) | ₹125.00 | View Details |